Downey Gregory 4
4 · Lexaria Bioscience Corp. · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Downey Gregory
Chief Financial Officer
Transactions
- Award
common shares
2022-10-14$2.09/sh+121$253→ 1,954 total
Holdings
- 4,000
Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 17,000
Stock Options
Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying) - 1,833
common shares
- 8,000
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 46,000
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (11,000 underlying) - 12,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 25,000
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (8,000 underlying) - 35,000
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)